ReviewMolecular medicine reports2024

Aryl hydrocarbon receptor: An emerging player in breast cancer pathogenesis and its potential as a drug target (Review).

Cong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.